» Authors » Amritha Suresh

Amritha Suresh

Explore the profile of Amritha Suresh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 968
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
James B, Zaidi S, Aiswarya R, Shetty V, Vidya Bhushan R, Dokhe Y, et al.
Hum Cell . 2025 Jan; 38(2):41. PMID: 39760828
The study explores the development and characterization of lymph node stromal cell cultures (LNSCs) from patients with oral squamous cell carcinoma (OSCC), highlighting the importance of understanding tumor-node cross-talk for...
2.
James B, Zaidi S, Bs N, R V, Dokhe Y, Shetty V, et al.
Oncol Lett . 2024 Sep; 28(5):540. PMID: 39310029
Profiling studies using reverse transcription quantitative PCR (RT-qPCR) require reliable normalization to reference genes to accurately interpret the results. A stable reference gene panel was established to profile metastatic and...
3.
Gurushanth K, Sunny S, Raghavan S, Thakur H, Majumder B, Srinivasan P, et al.
J Maxillofac Oral Surg . 2024 Aug; 23(4):816-823. PMID: 39118933
Objectives: Oral cancer is significantly high in India, and screening is an effective approach to downstage the disease. Educating Community Health Workers (CHWs) on early oral cancer detection is an...
4.
Kekatpure V, Subramaniam N, Sunny S, Nambiar S, Sarah T, Vasudevan V, et al.
Asian Pac J Cancer Prev . 2024 Jun; 25(6):1935-1943. PMID: 38918654
Objective: The 2x2 factorial design is an effective method that allows for multiple comparisons, especially in the context of interactions between different interventions, without substantially increasing the required sample size....
5.
Confer M, Falahkheirkhah K, Surendran S, Sunny S, Yeh K, Liu Y, et al.
J Pers Med . 2024 Mar; 14(3). PMID: 38541046
Oral potentially malignant disorders (OPMDs) are precursors to over 80% of oral cancers. Hematoxylin and eosin (H&E) staining, followed by pathologist interpretation of tissue and cellular morphology, is the current...
6.
Keerthi G, Mukhia N, Sunny S, Song B, Raghavan S, Gurudath S, et al.
Clin Oral Investig . 2023 Oct; 27(12):7575-7581. PMID: 37870594
Objectives: Oral cancer is a leading cause of morbidity and mortality. Screening and mobile Health (mHealth)-based approach facilitates early detection remotely in a resource-limited settings. Recent advances in eHealth technology...
7.
Sunny S, D R R, Hariharan A, Mukhia N, Gurudath S, G K, et al.
PLoS One . 2023 Sep; 18(9):e0291972. PMID: 37747904
The high prevalence of oral potentially-malignant disorders exhibits diverse severity and risk of malignant transformation, which mandates a Point-of-Care diagnostic tool. Low patient compliance for biopsies underscores the need for...
8.
Boreddy S, Nair R, Pandey P, Kuriakose A, Marigowda S, Dey C, et al.
Cancer Res . 2023 Apr; 83(11):1883-1904. PMID: 37074042
Significance: The bifunctional mAb fusion design of BCA101 targets it to the tumor microenvironment where it inhibits EGFR and neutralizes TGFβ to induce immune activation and to suppress tumor growth.
9.
Gurushanth K, Mukhia N, Sunny S, Song B, Raghavan S, Gurudath S, et al.
Res Sq . 2023 Apr; PMID: 37066209
Oral Cancer is one of the most common causes of morbidity and mortality. Screening and mobile Health (mHealth) based approach facilitates remote early detection of Oral cancer in a resource-constrained...
10.
Song B, Zhang C, Sunny S, Kc D, Li S, Gurushanth K, et al.
Cancers (Basel) . 2023 Mar; 15(5). PMID: 36900210
Convolutional neural networks have demonstrated excellent performance in oral cancer detection and classification. However, the end-to-end learning strategy makes CNNs hard to interpret, and it can be challenging to fully...